Eloxx Pharmaceuticals, Inc.
ELOX
$16.57
$0.402.47%
NASDAQ
| 06/30/2026 | 06/30/2025 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -19.93% | -10.65% | 30.32% | 1.41% | 15.84% |
| Total Depreciation and Amortization | -- | -- | -0.54% | 4.49% | -5.82% |
| Total Amortization of Deferred Charges | 14.29% | -100.00% | -60.83% | -16.67% | 3.60% |
| Total Other Non-Cash Items | 1,670.00% | 184.44% | -39.57% | 67.66% | -8.73% |
| Change in Net Operating Assets | 73.35% | -99.62% | 174.97% | -605.93% | 37.21% |
| Cash from Operations | 12.18% | -245.60% | 69.68% | -20.37% | 18.50% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | 27.27% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 27.27% | -- | 100.00% |
| Total Debt Issued | -- | 380.77% | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | -- | -- |
| Issuance of Common Stock | 150,637.50% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -98.70% | -- | -- | -- | -79.20% |
| Cash from Financing | 758.85% | 316.76% | 119.04% | -2,503.85% | -79.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3,423.26% | -64.01% | 95.64% | -167.40% | 2.64% |